Akb-6548-Ci-0017
Research payments
$13,190,668
Through program year 2022, $13,190,668 in research payments was reported against Akb-6548-Ci-0017, across 14,793 payments, paid by Akebia Therapeutics Inc.
- Paid by
- Akebia Therapeutics Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $80,136 | 1 |
| 2019 | Research | $13,110,532 | 14,792 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ahmad Aswad Miami, FL Named on 716 payments
- Harold Hubert Augusta, GA Named on 709 payments
- Robert Szewc San Antonio, TX Named on 570 payments
- Irfan Agha Dallas, TX Named on 506 payments
- Omaran Abdeen Mission Hills, CA Named on 469 payments
- Pablo Pergola San Antonio, TX Named on 432 payments
- Ahmed Awad Kansas City, MO Named on 430 payments
- Albert Matalon New York, NY Named on 395 payments
- Adeel Ijaz MacOmb, MI Named on 393 payments
- Arvind Mehta Long Beach, CA Named on 370 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.